Gilead has a least two things to consider regarding there pricing strategy.
#1- What Abbvie's price will be on there all oral treatment in Dec.2014 (Abbvie has the benefit of seeing how Sovaldi was receive by the Insurance and Medical institutions.) If they price higher that Abbvie then they will lose their lead in the HepC cure race.
#2- What will be the price difference between Sovaldi and the new combo SOL & LDV because most of the study trials for SOL & LDV have been for GT1. So Sovaldi will still have a place in the market Also what Gilead has to factor is, if they lower the price of Sovaldi to low then the other Drug companies that piggyback on Sovaldi like J&J and BMS could undercut the price of the new Gilead combo (SOL & LDV)
Its a real possibility that the new combo will be just 10% or 20% higher than Sovaldi that way they could compete with both Abbvie and any off label combo. (Just a thought)
matt
OldenSlow said
May 28, 2014
Fireman Rob wrote:
I read an article yesterday that said "health experts" estimate the soon-to-be-released Sovaldi/Ledispavir to cost an estimated $140,000. Lovely...
Pure speculation at this point, but I don't believe the cost will be this high. Gilead's feeling the heat. I suspect it will be reflected in the fall prices. Keeping the coupon program intact is critical, though.
Huey said
May 28, 2014
Tig56 wrote:
I hope MySupport Path keeps their payment assistance program in gear and have plenty of coupons at the ready....
Tig
Yes I would have to agree,
Fireman Rob said
May 28, 2014
Jimbob,
Yes, S/O is close to $150,000 together. It's a little depressing for those trying to obtain a int/riba free tx. Like Tig said, let's hope Support Path is here to stay.
jimbob said
May 28, 2014
Presently, isn't Sovaldi /Olysio combo the same price? Plus, I think the Sovaldi/Ledispavir combo will be more potent.
Tig said
May 28, 2014
I hope MySupportPath keeps their payment assistance program in gear and have plenty of coupons at the ready....
I read an article yesterday that said "health experts" estimate the soon-to-be-released Sovaldi/Ledispavir to cost an estimated $140,000. Lovely...
Huey said
May 28, 2014
I still think if Express Scripts offered to buy in bulk, like 11 million worth at a time, but at half cost, "to recover initial cost-they would have to do it 100 times but that is feasible, " When Gilead is operating in the margins the stock holders would get plenty, The demand is there why not??
-- Edited by Huey on Wednesday 28th of May 2014 11:40:20 PM
patiently_waiting said
May 28, 2014
When they say "sustainable" they mean "lower" cost, unless I'm misunderstanding what you're referring to in the article. My reading of it is just pretty much the same old story, the insurance companies are complaining about the high cost while the drug companies are claiming it's justified.
www.reuters.com/article/2014/05/20/insurance-gilead...Cached... the new $84,000 hepatitis C treatment from Gilead Sciences I
Cinnamon Girl said
May 21, 2014
Do you have a link to this article, please Huey?
Huey said
May 21, 2014
five paragraphs from the bottom, "Comparing the price of a pill or a bottle,, to treating it for life??? So does that mean if the cure is to high we all have to suffer and pay for life a cost for treatment that just sustains, when there is a cure????? What the H LL??
Gilead has a least two things to consider regarding there pricing strategy.
#1- What Abbvie's price will be on there all oral treatment in Dec.2014 (Abbvie has the benefit of seeing how Sovaldi was receive by the Insurance and Medical institutions.) If they price higher that Abbvie then they will lose their lead in the HepC cure race.
#2- What will be the price difference between Sovaldi and the new combo SOL & LDV because most of the study trials for SOL & LDV have been for GT1. So Sovaldi will still have a place in the market Also what Gilead has to factor is, if they lower the price of Sovaldi to low then the other Drug companies that piggyback on Sovaldi like J&J and BMS could undercut the price of the new Gilead combo (SOL & LDV)
Its a real possibility that the new combo will be just 10% or 20% higher than Sovaldi that way they could compete with both Abbvie and any off label combo. (Just a thought)
matt
Pure speculation at this point, but I don't believe the cost will be this high. Gilead's feeling the heat. I suspect it will be reflected in the fall prices. Keeping the coupon program intact is critical, though.
Yes I would have to agree,
Jimbob,
Yes, S/O is close to $150,000 together. It's a little depressing for those trying to obtain a int/riba free tx. Like Tig said, let's hope Support Path is here to stay.
I hope MySupportPath keeps their payment assistance program in gear and have plenty of coupons at the ready....
Tig
SUPPORT PATH PROGRAM: http://www.gilead.com/responsibility/us-patient-access
I read an article yesterday that said "health experts" estimate the soon-to-be-released Sovaldi/Ledispavir to cost an estimated $140,000. Lovely...
I still think if Express Scripts offered to buy in bulk, like 11 million worth at a time, but at half cost, "to recover initial cost-they would have to do it 100 times but that is feasible, " When Gilead is operating in the margins the stock holders would get plenty, The demand is there why not??
-- Edited by Huey on Wednesday 28th of May 2014 11:40:20 PM
U.S. health insurers say Gilead hepatitis C drug too costly ...
www.reuters.com/article/2014/05/20/insurance-gilead... Cached... the new $84,000 hepatitis C treatment from Gilead Sciences I
Do you have a link to this article, please Huey?
five paragraphs from the bottom, "Comparing the price of a pill or a bottle,, to treating it for life??? So does that mean if the cure is to high we all have to suffer and pay for life a cost for treatment that just sustains, when there is a cure????? What the H LL??